Cargando…

The impact of “World Health Organization - Government of India guidelines on chronic obstructive pulmonary diseases-2003” on quality of life

BACKGROUND: The World Health Organization-Government of India (WHO-GOI) Guidelines - 2003 for management of chronic obstructive pulmonary diseases (COPD) is a consensus statement. However, the outcome and impact of its implementation on quality of life (QOL) among COPD patients has not been studied...

Descripción completa

Detalles Bibliográficos
Autores principales: Janmeja, Ashok K., Mohapatra, Prasanta R., Kumar, Mandeep
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876692/
https://www.ncbi.nlm.nih.gov/pubmed/20531989
http://dx.doi.org/10.4103/0970-2113.56341
_version_ 1782181697096253440
author Janmeja, Ashok K.
Mohapatra, Prasanta R.
Kumar, Mandeep
author_facet Janmeja, Ashok K.
Mohapatra, Prasanta R.
Kumar, Mandeep
author_sort Janmeja, Ashok K.
collection PubMed
description BACKGROUND: The World Health Organization-Government of India (WHO-GOI) Guidelines - 2003 for management of chronic obstructive pulmonary diseases (COPD) is a consensus statement. However, the outcome and impact of its implementation on quality of life (QOL) among COPD patients has not been studied so far. MATERIALS AND METHODS: The patients were randomized to intervention group (n = 50) and control group (n = 40). All were treated and followed up for 6 months. A pulmonary physician reviewed patients of both the groups, at least 3 times in 6 months period. St. George's Respiratory Questionnaire was measured at baseline and at 6 months. Patients in control group visited the center on a “need to” basis and were prescribed conventional treatment by the doctor on duty. RESULTS: Forty-two patients in the intervention group and 32 in the control group completed 3 visits over the period of 6 months and were included in analysis. The severity as per the guidelines was moderate in 74% and severe in 26% in intervention group while it was moderate in 64% and severe in 36% cases in control group. Follow-up QOL scores were significantly better as compared with baseline values (P < 0.001). The QOL of the patients treated according to the guidelines were significantly better (P < 0.001) than those in the control group with conventional treatment. CONCLUSION: The consensus derived recommendations of WHO-GOI Guidelines for COPD-2003 are beneficial for management of COPD patients over conventional management.
format Text
id pubmed-2876692
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-28766922010-06-08 The impact of “World Health Organization - Government of India guidelines on chronic obstructive pulmonary diseases-2003” on quality of life Janmeja, Ashok K. Mohapatra, Prasanta R. Kumar, Mandeep Lung India Original Article BACKGROUND: The World Health Organization-Government of India (WHO-GOI) Guidelines - 2003 for management of chronic obstructive pulmonary diseases (COPD) is a consensus statement. However, the outcome and impact of its implementation on quality of life (QOL) among COPD patients has not been studied so far. MATERIALS AND METHODS: The patients were randomized to intervention group (n = 50) and control group (n = 40). All were treated and followed up for 6 months. A pulmonary physician reviewed patients of both the groups, at least 3 times in 6 months period. St. George's Respiratory Questionnaire was measured at baseline and at 6 months. Patients in control group visited the center on a “need to” basis and were prescribed conventional treatment by the doctor on duty. RESULTS: Forty-two patients in the intervention group and 32 in the control group completed 3 visits over the period of 6 months and were included in analysis. The severity as per the guidelines was moderate in 74% and severe in 26% in intervention group while it was moderate in 64% and severe in 36% cases in control group. Follow-up QOL scores were significantly better as compared with baseline values (P < 0.001). The QOL of the patients treated according to the guidelines were significantly better (P < 0.001) than those in the control group with conventional treatment. CONCLUSION: The consensus derived recommendations of WHO-GOI Guidelines for COPD-2003 are beneficial for management of COPD patients over conventional management. Medknow Publications 2009 /pmc/articles/PMC2876692/ /pubmed/20531989 http://dx.doi.org/10.4103/0970-2113.56341 Text en © Lung India http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Janmeja, Ashok K.
Mohapatra, Prasanta R.
Kumar, Mandeep
The impact of “World Health Organization - Government of India guidelines on chronic obstructive pulmonary diseases-2003” on quality of life
title The impact of “World Health Organization - Government of India guidelines on chronic obstructive pulmonary diseases-2003” on quality of life
title_full The impact of “World Health Organization - Government of India guidelines on chronic obstructive pulmonary diseases-2003” on quality of life
title_fullStr The impact of “World Health Organization - Government of India guidelines on chronic obstructive pulmonary diseases-2003” on quality of life
title_full_unstemmed The impact of “World Health Organization - Government of India guidelines on chronic obstructive pulmonary diseases-2003” on quality of life
title_short The impact of “World Health Organization - Government of India guidelines on chronic obstructive pulmonary diseases-2003” on quality of life
title_sort impact of “world health organization - government of india guidelines on chronic obstructive pulmonary diseases-2003” on quality of life
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876692/
https://www.ncbi.nlm.nih.gov/pubmed/20531989
http://dx.doi.org/10.4103/0970-2113.56341
work_keys_str_mv AT janmejaashokk theimpactofworldhealthorganizationgovernmentofindiaguidelinesonchronicobstructivepulmonarydiseases2003onqualityoflife
AT mohapatraprasantar theimpactofworldhealthorganizationgovernmentofindiaguidelinesonchronicobstructivepulmonarydiseases2003onqualityoflife
AT kumarmandeep theimpactofworldhealthorganizationgovernmentofindiaguidelinesonchronicobstructivepulmonarydiseases2003onqualityoflife
AT janmejaashokk impactofworldhealthorganizationgovernmentofindiaguidelinesonchronicobstructivepulmonarydiseases2003onqualityoflife
AT mohapatraprasantar impactofworldhealthorganizationgovernmentofindiaguidelinesonchronicobstructivepulmonarydiseases2003onqualityoflife
AT kumarmandeep impactofworldhealthorganizationgovernmentofindiaguidelinesonchronicobstructivepulmonarydiseases2003onqualityoflife